Emergent BioSolutions Inc. SEC filings EBS
Emergent BioSolutions Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Dec 29, 2014. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Mar 20, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 27, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Mar 21, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 4, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 11, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 8, 2024 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Dec 11, 2023 | Dec 31, 2022 |
| ARS | Annual report to shareholders | Apr 14, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 1, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 25, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Feb 19, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Feb 25, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Feb 22, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Feb 23, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Feb 28, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Feb 29, 2016 | Dec 31, 2015 |
| 10-K/A | Amended annual report | Mar 9, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Mar 6, 2015 | Dec 31, 2014 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EBS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Gaithersburg, MD
- SEC filer status
- Accelerated filer
- SEC CIK
- 1367644
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.